AI-Enabled Imaging Modalities Market to Surge from $3.62 Billion to $15.16 Billion by 2035, Driven by Deep Learning and Hospital Demand
Key Insights
The global AI-enabled imaging modalities market is projected to grow from USD 3.62 billion in 2025 to USD 15.16 billion by 2035 at a 15.9% CAGR, according to InsightAce Analytic.
Hospitals represented the largest market share in 2025, fueled by rising adoption of AI-based solutions to enhance diagnostic accuracy and workflow efficiency.
Deep learning technology is expected to grow at the highest rate, enabling precise abnormality detection across CT, MRI, mammography, ultrasound, and X-ray modalities.
The global market for AI-enabled imaging modalities is poised for transformative growth over the next decade, with revenues expected to climb from USD 3.62 billion in 2025 to USD 15.16 billion by 2035, reflecting a compound annual growth rate (CAGR) of 15.9%, according to a new report from InsightAce Analytic.
AI-enabled imaging systems integrate artificial intelligence—including machine learning, deep learning, computer vision, and advanced data analytics—with medical imaging technologies such as X-ray, CT, MRI, ultrasound, mammography, and nuclear imaging. These systems are designed to assist radiologists in detecting abnormalities, prioritizing urgent cases, enhancing image quality, and reducing reporting turnaround times.
Hospitals Drive Market Adoption
The hospitals segment captured the largest share of the AI-enabled imaging modality market in 2025. This dominance is attributed to the high volume of diagnostic imaging procedures performed in hospital settings and the accelerating adoption of AI-based solutions aimed at improving operational efficiency and diagnostic precision.
"Healthcare organizations are investing more in AI-driven imaging platforms to lower diagnostic mistakes, increase workflow efficiency, and tackle the shortage of qualified radiologists," the report states, underscoring the operational pressures facing modern radiology departments.
Deep Learning Leads Technology Growth
Among the technological approaches underpinning AI-enabled imaging, deep learning is forecast to register the highest growth rate during the forecast period. The technology's ability to accurately detect abnormalities across multiple imaging modalities—including CT, MRI, mammography, ultrasonography, and X-ray—positions it as a critical enabler of diagnostic innovation.
The rising burden of chronic diseases, growing demand for early and accurate diagnosis, and increasing pressure on healthcare providers to enhance productivity are cited as primary growth catalysts. Additionally, improvements in cloud computing, digital health infrastructure, and AI algorithms are accelerating market expansion across both developed and emerging healthcare systems.
North America Maintains Regional Leadership
North America held the leading position in the AI-driven imaging modalities market in 2025, supported by a well-established healthcare system, high penetration of artificial intelligence technologies, and substantial funding directed toward imaging technology development.
The region benefits from a dense ecosystem of large imaging equipment manufacturers, AI software developers, and academic research institutions, which collectively facilitate rapid product development and commercialization. Government support for digital health initiatives, favorable reimbursement policies, and growing AI adoption in radiology further reinforce North America's market dominance.
Competitive Landscape and Recent Developments
The competitive field features a mix of established imaging equipment manufacturers and specialized AI software developers. Key players include GE HealthCare, Siemens Healthineers (search), Philips Healthcare, Canon Medical Systems Corporation (search), Fujifilm Holdings Corporation, Samsung Medison, Hologic Inc., as well as AI-focused firms such as Aidoc (search), Viz.ai (search), Qure.ai (search), Gleamer, Lunit Inc., Arterys, HeartFlow Inc., Subtle Medical, and NVIDIA Corporation (search).
Several notable developments have shaped the market in recent months. In May 2025, GE HealthCare expanded its portfolio of AI-enabled imaging applications with advanced intelligent imaging tools designed to enhance image reconstruction and clinical decision-making. Siemens Healthineers (search) updated its AI-Rad Companion application suite in April 2025, adding automated image analysis capabilities for CT and MRI scans. Philips Healthcare launched new AI-based MRI and CT imaging systems in February 2025, delivering higher resolution images, faster scanning processes, and integrated clinical decision support. In October 2024, Qure.ai (search) updated its AI algorithms for chest X-ray and CT image analysis to improve detection of pulmonary diseases and neuroanatomical changes.
Regulatory and Implementation Challenges
Despite strong growth momentum, the market faces significant hurdles. The lengthy regulatory approval process for AI-based software and imaging technology remains a primary challenge, requiring companies to provide robust evidence of product effectiveness and reliability before commercialization. Additional concerns include patient data security, cybersecurity vulnerabilities, compatibility with existing hospital management systems and PACS infrastructure, and the high capital costs associated with installing AI-enabled imaging technologies.
The growing adoption of precision medicine, increasing acceptance of value-based healthcare models, and sustained investments in medical imaging innovation are expected to open new growth avenues. Ongoing partnerships between imaging equipment manufacturers, AI software developers, and healthcare providers are likely to further accelerate market adoption in the coming years.